ABEONA THERAPEUTICS INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Abeona Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Abeona Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$30.3M, a 156% decline year-over-year.
  • Abeona Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$71M, a 58.8% decline year-over-year.
  • Abeona Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$54.2M, a 36.5% decline from 2022.
  • Abeona Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$39.7M, a 53.3% increase from 2021.
  • Abeona Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$84.9M, a 0.83% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$71M -$30.3M -$18.4M -156% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$52.6M $7.41M +$24.1M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$76.7M -$31.6M -$22.5M -247% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$54.2M -$16.6M -$9.47M -133% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 -$44.7M -$11.8M -$5.4M -84% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$39.3M -$16.7M -$12.6M -306% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$26.8M -$9.11M +$12.9M +58.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$39.7M -$7.12M +$39.6M +84.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 -$79.3M -$6.43M +$610K +8.66% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$79.9M -$4.1M +$11.1M +73.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$91M -$22M -$6.04M -37.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$84.9M -$46.7M -$30.9M -195% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$54.1M -$7.04M +$193K +2.67% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$54.3M -$15.2M -$2.2M -16.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$52.1M -$16M +$32.2M +66.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$84.2M -$15.8M +$603K +3.67% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$84.8M -$7.24M +$10.1M +58.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$95M -$13M +$10.9M +45.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 -$106M -$48.2M -$29.6M -160% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$76.3M -$16.4M +$1.05M +6% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$77.3M -$17.4M -$953K -5.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$76.4M -$23.9M -$11.7M -95.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$64.7M -$18.6M -$8.03M -76.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-08-10
Q4 2018 -$56.7M -$17.5M -$9.03M -107% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$47.6M -$16.4M -$11.1M -207% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$36.6M -$12.2M -$3.96M -47.9% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$32.6M -$10.5M -$5.28M -101% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$27.3M -$8.45M -$1.45M -20.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$25.9M -$5.34M -$2.72M -104% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$23.2M -$8.28M -$1.58M -23.5% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$21.6M -$5.25M +$297K +5.36% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$21.9M -$7M -$4.66M -199% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 -$17.2M -$2.62M +$3.45M +56.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$20.7M -$6.7M -$2.59M -63% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$18.1M -$5.54M -$3.54M -177% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$14.5M -$2.34M +$9.6M +80.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$24.1M -$6.07M -$4.6M -313% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$19.5M -$4.11M +$8.39M +67.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$27.9M -$2M -$1.14M -133% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$26.8M -$11.9M -$10.9M -1011% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$15.9M -$1.47M -$1.31M -836% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$14.6M -$12.5M -$14.1M -882% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-08-14
Q1 2014 -$491K -$859K -$4.94M -121% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $4.45M -$1.08M -$20.9M -105% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 $25.4M -$157K +$14.7M +98.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $10.6M $1.6M +$12.2M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$1.56M $4.08M +$8.97M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$10.5M $19.8M +$19.5M +6956% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-26
Q3 2012 -$30.1M -$14.9M -$15.2M -4348% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$14.9M -$10.6M -$9.34M -739% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$5.53M -$4.89M -$2.99M -158% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$2.53M $281K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-20
Q3 2011 $350K +$13.1M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$1.26M -$3.05M -171% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$1.9M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$12.7M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $1.79M Apr 2, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.